| Literature DB >> 27264604 |
Gerard E Kaiko1, Stacy H Ryu1, Olivia I Koues1, Patrick L Collins1, Lilianna Solnica-Krezel2, Edward J Pearce1, Erika L Pearce1, Eugene M Oltz1, Thaddeus S Stappenbeck3.
Abstract
In the mammalian intestine, crypts of Leiberkühn house intestinal epithelial stem/progenitor cells at their base. The mammalian intestine also harbors a diverse array of microbial metabolite compounds that potentially modulate stem/progenitor cell activity. Unbiased screening identified butyrate, a prominent bacterial metabolite, as a potent inhibitor of intestinal stem/progenitor proliferation at physiologic concentrations. During homeostasis, differentiated colonocytes metabolized butyrate likely preventing it from reaching proliferating epithelial stem/progenitor cells within the crypt. Exposure of stem/progenitor cells in vivo to butyrate through either mucosal injury or application to a naturally crypt-less host organism led to inhibition of proliferation and delayed wound repair. The mechanism of butyrate action depended on the transcription factor Foxo3. Our findings indicate that mammalian crypt architecture protects stem/progenitor cell proliferation in part through a metabolic barrier formed by differentiated colonocytes that consume butyrate and stimulate future studies on the interplay of host anatomy and microbiome metabolism.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27264604 PMCID： PMC5026192 DOI： 10.1016/j.cell.2016.05.018
Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582